title: [Chemotherapy definitions and policies for thymic malignancies].
authors.affiliation: Department of Respiratory Medicine, Louis Pradel Hospital Hospices Civils de Lyon, Lyon (Bron), France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Girard
authors.affiliation: Cancer Services, Guy's and St. Thomas' Cancer Centre, London, United Kingdom.
authors.forename: Rohit
authors.initials: R
authors.lastname: Lal
authors.affiliation: Division of Oncology, depart-ment of Medicine, Stanford University, Stanford, California.
authors.forename: Heather
authors.initials: H
authors.lastname: Wakelee
authors.affiliation: Thoracic Oncology Service, Memorial Sloan Kettering Hospital, New York, New York.
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Riely
authors.affiliation: Division of Hematology and Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana.
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Loehrer
mesh_terms: D004358:Drug Therapy / Q000592:standards*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D006854:Hydrocortisone